Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Respiratory Monitoring Medtech Firm Appoints Global Expert Dr. Peter Small as Chief Medical Officer
Fast-growing AI Medtech company Hyfe has, today, announced the appointment of world-renowned Seattle-based physician and […]
Babylon Gives Millions More Rwandans Access to Digital-first Healthcare in Next Step Towards Digitising Rwanda's Healthcare System
Babylon, in collaboration with Rwanda’s National ID Agency (NIDA), have taken another step towards creating one of Africa’s most […]
Anocca Appoints Jacob Michlewicz as CFO
Anocca AB, a leader in unlocking the potential of T-cell immunotherapy to deliver transformative therapeutics, […]
G20 Ministerial Health Declaration Published
G20 health ministers have united to pledge global action to improve future health security, increase […]
binx health Adds Industry Leaders, Elizabeth Mora and Naomi Kelman to Board of Directors
binx health, a healthcare technology and diagnostics company that brings convenient care to the locations […]
Medable Hires Chief Strategy Officer to Expand Global Partner and Innovation Ecosystem for Decentralized Clinical Trials
Medable Inc., the leading cloud platform for patient-centered drug development, today announced the hiring of Dr. […]
Global Fund Results Report Reveals COVID-19 Devastating Impact on HIV, TB and Malaria Programs
The COVID-19 pandemic had a devastating impact on the fight against HIV, TB and malaria […]
Provepharm Life Solutions Raises €120 Million
Provepharm Life Solutions, a private French pharmaceutical company that finds new applications for well-known molecules, […]
Newron Initiates First Potentially Pivotal Study with Evenamide in Patients with Schizophrenia
Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of […]
Drug Could Help Hearts Recover After Heart Attack
A drug used to treat certain cancers could improve recovery after a heart attack by […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more